XML 73 R57.htm IDEA: XBRL DOCUMENT v3.24.4
Segment Information (Segment Profit by Reportable Segment) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total operating earnings $ 549 $ 505 $ 1,117 $ 473
Operating Segments        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total operating earnings 667 612 1,309 1,176
Operating Segments | Pharmaceutical and Specialty Solutions        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total operating earnings 531 495 1,061 951
Operating Segments | Global Medical Products and Distribution        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total operating earnings 18 11 26 23
Operating Segments | Other Segments        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total operating earnings 118 106 222 202
Corporate        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total operating earnings $ (118) $ (107) $ (192) $ (703)